














to	 develop	 new	 antimicrobials.	 We	 demonstrate	 that	 GATG	 dendrimers	 functionalised	 with	 primary	 amines	 in	 their	
periphery	 can	 induce	 the	 formation	 of	 clusters	 in	 Vibrio	 harveyi,	 an	 opportunistic	 marine	 pathogen,	 in	 a	 generation	
dependent	 manner.	 Moreover,	 these	 cationic	 GATG	 dendrimers	 demonstrate	 an	 improved	 ability	 to	 induce	 cluster	
formation	 when	 compared	 to	 poly(N-[3-(dimethylamino)propyl]methacrylamide)	 [p(DMAPMAm)],	 a	 cationic	 linear	
polymer	 previously	 shown	 to	 cluster	 bacteria.	 Viability	 of	 the	 bacteria	 within	 the	 formed	 clusters	 and	 evaluation	 of	
quorum	 sense	 controlled	 phenotypes	 (i.e.	 light	 production	 in	 Vibrio	 harveyi)	 suggests	 that	 GATG	 dendrimers	 may	 be	
activating	microbial	 responses	 by	maintaining	 a	 high	 concentration	 of	 quorum	 sensing	 signals	 inside	 the	 clusters	while	







but	 also	 in	 exploring	 novel	 antimicrobial	 strategies3,	 4	 which	
minimise	 the	 impact	 of	 infection	 without	 targeting	 microbial	
viability.5	Anti-virulence	methods	target	key	stages	in	infection	
such	as	the	adhesion	of	the	pathogen	to	the	host6,	7	or	the	sig-
nalling	 networks	 that	 coordinate	 the	 expression	 of	 virulence	
factors.8,	9	Because	these	strategies	do	not	compromise	micro-
bial	 viability	 and	 survival,	 the	 evolutionary	 pressure	 imposed	
on	microbes	is	much	smaller	than	with	conventional	antibiotics	
and	hence,	resistance	is	less	likely	to	develop.10	Moreover,	an-





and	 Gram-negative	 bacteria.12	 Polymers	 are	 inherently	multi-
valent	 and	 thus	 can	 be	 designed	 to	 outcompete	 the	 ligand-
binding	 interactions	 observed	 during	 the	 adhesion	 of	 patho-
gens	 and	 toxins	 to	 hosts.13	 Since	 this	 adhesion	 is	 heavily	 af-
fected	by	the	spatial	arrangement	of	the	 ligands,	 it	 is	not	sur-
prising	that	a	major	effort	has	been	placed	in	using	dendrimers	
for	 preventing	 microbial	 attachment.14,	 15	 Indeed,	 the	 mono-
dispersity	of	dendrimers	is	a	key	advantage	when	interpreting	







Alternatively,	 polymeric	 materials	 have	 been	 investigated	 as	
readily	 accessible	mimics	of	 antimicrobial	 peptides.26-28	 These	
antimicrobial	polymers	exert	a	bactericidal	effect	by	 targeting	
bacterial	membranes.	The	combination	of	cationic	charge	and	
hydrophobic	 character	 in	 antimicrobial	 polymers	 gives	 them	
interesting	 membrane	 properties,	 including	 increasing	 cell	
membrane	permeability,	that	can	result	in	bactericidal	activity	
through	lysis.	
Here,	 we	 investigate	 the	 use	 of	 gallic	 acid-triethylene	 glycol	
(GATG)	 dendrimers29	 as	 a	 platform	 for	 the	 development	 of	
novel	antimicrobial	agents.	We	have	focussed	our	attention	in	
3	 areas	 –	 adhesion/clustering,	 signalling	 and	 membrane	 dis-
ruption	–	because	of	the	relevance	of	polymeric	materials.	The	





troduces	great	 flexibility	 in	 their	peripheral	decoration.	These	
azides	 can	be	easily	 functionalized	using	highly	 efficient	 click-
chemistries,	and	not	 surprisingly,	 the	 resulting	materials	have	
found	application	in	the	study	of	receptor-ligand	interactions30,	




in	gene	delivery.36,	 37	Bacteria	are	negatively	 charged,	 so	 cati-
onic	materials	are	also	an	obvious	starting	point	 in	 the	devel-
opment	 of	 antimicrobial	 agents	 that	 cluster	 bacteria,12,	 17,	 18	
potentially	 inhibiting	 their	 adhesion	 to	 the	 host.	 In	 addition,	
adhesion	of	cationic	materials	to	bacterial	membranes	can	re-
sult	in	membrane	damage	and	bactericidal	activity.26-28		
Using	 Vibrio	 harveyi	 as	 a	 model	 organism,	 here	 we	 demon-
strate	 that	 three	 generations	of	GATG	dendrimers	 carrying	9,	
27	and	81	primary	amines	in	their	periphery	(Scheme	1)	induce	
clustering	 of	 bacteria	 in	 a	 generation	 dependent	 fashion	 and	
that	 their	 ability	 to	 cluster	 bacteria	 is	 higher	 than	
p(DMAPMAm),	a	cationic	linear	polymer	previously	used	in	our	
laboratories.	 Also,	 we	 demonstrate	 that	 quorum	 sense	 con-
trolled	expression	of	luminescence	by	V.	harveyi	is	activated	in	





Triphenyl	 phosphine	was	 purchased	 from	 Sigma-Aldrich®	 and	
recrystallized	from	ethanol.	Phosphate	Buffer	Saline	(PBS,	Dul-
becco	 A)	 was	 purchased	 from	 Oxoid.	 4,5-Dihydroxy-2,3-
pentandione	 (DPD)	 was	 purchased	 from	 Ommcientific®.	
p(DMAPMAm),	degree	of	polymerisation	46	and	99,	was	 syn-
thesised	 according	 to	 protocols	 described	 in	 the	 literature18.	
All	 other	 chemicals	 were	 purchased	 from	 Sigma-Aldrich	 or	
Acros	and	were	used	without	 further	purification.	All	solvents	
were	 of	 HPLC	 grade	 and	 purchased	 from	 Sigma-Aldrich	 or	
Fisher	 Scientific	 and	 used	 without	 further	 purification.	 Bac-
light™	Bacterial	Viability	kit	 (L32856)	was	purchased	from	Life	
technologies™	 and	used	 for	 fluorescent	 live/dead	staining	 for	









ing	 KBr	 pellets	 or	 neat	 samples	 (CsI	window).	MALDI-TOF	MS	
of	 the	 dendrimers	 at	 the	 azide	 stage	 were	 performed	 on	 a	
4800	 MALDI-TOF/TOF	 analyser	 (Applied	 Biosystems)	 with	
samples	dissolved	in	MeOH	supplemented	with	NaCl	as	cation-
izing	agent,	and	2-(4-hydroxyphenylazo)benzoic	acid	(HABA)	or	
2,5-dihydroxybenzoic	 acid	 (DHB)	 as	 matrixes.	 Dendrimer	 hy-
drodynamic	diameters	and	ζ-potentials	were	measured	by	dy-
namic	 light	 scattering	 (DLS)	 and	 laser	 Doppler	 micro-
electrophoresis	 on	 a	 Nano-S	 Zetasizer	 (Malvern	 Instrument	







fore	 injection.	 Size	 of	 bacterial	 clusters	 was	 measured	 on	 a	
Coulter	 LS230	 particle	 size	 analyser	 (Beckman	 Coulter,	 High	
Wycombe,	USA)	using	laser	diffraction.	ζ-potential	for	bacteria	
clusters	was	measured	on	a	NanoZS	ZEN3600	Malvern	Zetasiz-











was	 confirmed	 by	 a	 Cary	 Eclipse	 fluorimeter.	 Flow	 cytometry	
was	 performed	 on	 a	 BD	 LSRII	 Flow	 Cytometer.	 Luminescence	
and	OD600	were	measured	in	a	Tecan	Infinite	Pro	200	Reader.	
Dendrimer	synthesis	
Three	 generations	 of	 cationic	 GATG	 dendrimers	 (3[Gn]-




with	PPh3	 in	 a	MeOH	–	CHCl3	 –	H2O	mixture	 and	 then	proto-
nated	 with	 HCl	 to	 obtain	 Gn-NH2·HCl	 dendrimers.	 Reactions	
were	monitored	by	 1H-NMR	 (disappearance	of	 the	CH2N3	 sig-
nal	at	3.35-3.39.ppm)	and	FT-IR	(disappearance	of	the	charac-
teristic	azide	peak	at	2100	cm-1)	that	confirmed	a	complete	re-
duction	of	 the	azide	groups	 (see	ESI	 for	 further	details).	After	
solvent	 evaporation	 the	 crude	 was	 dissolved	 in	 H2O	 and	 fil-





(s,	 3H),	 4.32	 -	 4.26	 (m,	 18H),	 4.10	 -	 4.09	 (m,	 6H),	 3.95	 –	3.72	
(m,	 96H),	 3.64	 –	 3.62	 (m,	 6H),	 3.21	 –	 3.17	 (m,	 18H).	 IR	 (KBr)	






24H),	 6.17	 (s,	 3H),	 4.29	 -	 4.20	 (m,	 72H),	 4.11	 -	 4.09	 (m,	 6H),	
3.93	 –	 3.72	 (m,	 312H),	 3.62	 –	 3.60	 (m,	 24H),	 3.19	 –	 3.16	 (m,	
54H).	 IR	 (KBr)	νmax:	 2929,	 1638,	 1118	 cm
-1.	MALDI-TOF	MS	of	






3.60	 (m,	 1038H),	 3.20	 –	 3.16	 (m,	 162H).	 IR	 (KBr)	 νmax:	 2878,	
1638,	1117	cm-1.			
Fluorescent	labelling	of	G3-NH2		
Stock	 solutions	 of	 7-methoxycoumarin-3-carboxylic	 acid	






solved	 in	 600	 μL	 of	 dry	 MeOH.	 This	 dendrimer	 solution	 was	
then	added	 slowly	 to	 the	previous	mixture	under	 stirring	 and	
stirred	 overnight.	 The	 solvent	was	 removed	under	 a	 nitrogen	





of	Molecular	 Biology,	 Princeton	University).	V.	 harveyi	 BB170	
was	grown	from	a	frozen	stock	on	Luria	Bertani	(LB)	agar	plates	








9,000	 rpm	 for	 5	min	 at	 4	 °C,	 the	 supernatant	 was	 discarded	
and	 bacteria	 re-suspended	 in	 PBS.	 This	 washing	 step	was	 re-
peated	two	times	and	bacteria	were	finally	re-suspended	at	an	







cated	 by	 the	 in-built	 display	 software.	 Aliquots	 of	 the	 den-
drimer-bacteria	 suspension	 in	 PBS	 were	 taken	 at	 different	
times	 (5-60	min	 range)	and	added	 to	a	Coulter	 flow	cell	 filled	
with	 H2O	 (<14	 mL)	 to	 reach	 the	 required	 optical	 obstruction	
indicated	by	 the	built-in	 software	 (8-12%,	between	500-1,500	
µL).	 Particle	 size	 ranges	 were	 defined	 using	 PSS-Duke	 stand-
ards	(Polymer	Standard	Service),	Kromatek	Ltd.,	Dunmow,	UK).	
Particle	 size	 or	 cluster	 size	 distribution	 was	 determined	 as	 a	
function	of	 the	particle	diffraction	using	 the	Coulter	 software	
(version	 2.11)	 and	plotted	 as	 a	 function	 of	 the	 percentage	 of	
distribution	volume.	Cluster	size	was	measured	 in	triplicate	at	
each	time	point.	Experiment	was	repeated	three	times.	
Microscopy:	10	µL	of	 the	Gn-NH2–bacteria	 suspension	 in	 PBS	




teria	 in	 PBS	 and	 incubated	 for	 60	 min.	 1	 µL	 of	 SYTO-9	 stain	















ed	 for	1	h	at	 room	temperature.	1	µL	of	a	mixture	of	 SYTO-9	












for	5	min	at	9,000	 rpm	and	 re-suspended	 in	500	µL	of	0.85%	
NaCl.	 1	µL	of	 a	mixture	of	 SYTO-9	 stain	 (0.033	mM	 in	DMSO)	
and	PI	(200	mM	in	DMSO)	1:1	was	added	to	each	sample	and	
incubated	at	room	temperature	in	the	dark	for	10	min	prior	to	
experiment.	 Negative	 controls	 were	 incubated	 with	 70%	 i-
PrOH	for	1	h	followed	by	2	washes	with	media	(centrifugation	




condition	 was	 done	 in	 triplicate	 and	 the	 experiment	 was	 re-




inoculate	 2	 mL	 LB	 medium	 containing	 50	 µg/mL	 kanamycin	









each	 time	point.	 Luminescence	 recovery	 time	was	 defined	 as	
the	time	for	normalised	luminescence	to	reach	the	initial	value	
for	each	individual	sample.	Each	compound	was	tested	over	at	
least	 3	 different	 concentrations	 and	 each	 concentration	 was	






Dendrimers	 are	 attractive	 materials	 to	 interface	 with	
biology.41-43.	They	are	monodisperse	polymers,	with	controlled	
sizes	and	numbers	of	terminal	groups	that	can	present	biologi-
cal	 information	 (e.g.	multiple	 copies	 of	 ligands	 or	 drugs)	 in	 a	
precise	and	unique	spatial	arrangement.	Not	surprisingly,	den-
drimers	 have	 been	 investigated	 as	 mimics	 of	 natural	 ligands	
(e.g.	glycans)	and	exploited	to	interfere	with	host-pathogen	in-
teractions.13-15	 In	this	work,	we	decided	to	 investigate	the	po-














gallic	acid	core,	 this	new	family	 is	expected	 to	display	a	more	
globular	 architecture.	 Dendrimers	 with	 9,	 27	 and	 81	 primary	
amines,	corresponding	to	generations	G1-NH2	–	G3-NH2,	were	
obtained	 by	 quantitative	 reduction	 of	 the	 peripheral	 azides,	
easily	 monitored	 using	 FT-IR	 spectroscopy	 (Figure	 S1)	 (com-
plete	disappearance	of	 the	azide	 signal	 at	2100	cm-1)	and	de-
termined	 by	 1H-NMR	 (disappearance	 of	 the	 CH2N3	 peak	 at	
3.35-3.39	ppm)	(Figure	S2).40	
Clustering	of	V.	harveyi	by	Gn-NH2	
The	 first	 potential	 antimicrobial	 strategy	 that	 we	 evaluated	
was	adhesion	and	clustering	of	bacteria.	Previous	work	 in	our	
group	 has	 shown	 that	 linear	 cationic	 polymers	 readily	 form	
polymer-bacteria	clusters	by	electrostatic	interactions	with	the	
negatively	 charged	 bacterial	 surface.12,	 17,	 18	 Herein,	 by	 using	
aminodendrimers	 where	 the	 size	 and	 number	 of	 terminal	
groups	 can	 be	 accurately	 controlled	 by	 design,	 we	 aimed	 to	
modulate	 systematically	 the	antimicrobial	 properties	of	 these	
polycations.	 We	 anticipated	 that	 the	 globular	 and	 branched	
architecture	of	GATG	dendrimers	would	have	a	beneficial	gen-
eration	 dependent	 effect	 on	 their	 interaction	 with	 bacterial	
membranes	and	thus	in	clustering.	As	 in	our	previous	reports,	
we	 used	 V.	 harveyi,	 an	 opportunistic	 marine	 pathogen,	 as	 a	
model	organism.	It	is	closely	related	to	human	pathogens	Vib-
rio	 cholerae	 and	 Vibrio	 parahaemolyticus	 and,	 like	 these	 mi-
crobes,	uses	a	complex	signalling	network	to	regulate	 its	viru-




a	 clear	 generation	 dependent	 increase	 in	 cluster	 formation	
could	be	observed	 (Figure	2).	 The	ability	of	 these	dendrimers	
to	cluster	bacteria	was	compared	to	linear	p(DMAPMAm),	pre-
viously	used	in	our	laboratories	for	this	purpose.	The	high	clus-
tering	 ability	 of	 GATG	 dendrimers	 allowed	 for	 these	 experi-
ments	 to	 be	 performed	 in	 PBS	which	was	 significant	 because	
under	 these	 conditions	 none	 of	 the	 p(DMAPMAm)	 polymers	
tested	(DP46	and	DP99)	were	able	to	 induce	any	clustering	of	
V.	 harveyi	 (Figure	 2A).	While	 no	 apparent	 increase	 in	 cluster	
size	 was	 observed	 for	 G1-NH2,	 which	 only	 has	 9	 primary	






tion	 centred	 at	 1	 μm)	was	 reduced.	 A	 similar	 effect	 could	 be	





croscope	 (Figure	2C),	with	aggregates	of	 increasing	 size	 form-
ing	with	increasing	dendrimer	generation.	
It	is	worth	noting	that	the	average	size	obtained	for	the	bacte-
ria	 in	 the	presence	of	G1-NH2	was	slightly	smaller	 (orange	tri-
angles,	 Figure	1B,	∼0.6	μm)	 than	 that	of	V.	harveyi	 in	 the	ab-
sence	of	the	dendrimers	(black	triangles,	Figure	1B,	∼0.9	μm).	
However,	 since	 reported	bacteria	 sizes	 are	measured	 relative	
to	 calibrants	 (i.e.	 polystyrene	 beads),	 they	 do	 not	 represent	
the	 actual	 size	 expected	 for	V.	 harveyi	 (∼1.5	 μm),	 but	 do	 in-
form	of	relative	changes	in	size.	Taking	into	account	the	size	of	
these	dendrimers	 (less	 than	3	nm	for	G1-NH2,	3.6	nm	for	G2-
NH2,	 and	5.7	nm	 for	G3-NH2;	 Table	 S1),	 it	 is	quite	 reasonable	
that	 G1-NH2	 does	 not	 have	 the	 minimum	 required	 size	 and	
multivalency	 to	 efficiently	 bridge	 between	 multiple	 bacteria	
and	none	or	few	small	clusters	are	formed.	Size	distributions	in	
the	presence	of	G1-NH2	were	narrower	(0.25-1.05	μm)	than	in	
its	 absence	 (0.30-3.00	μm),	 suggesting	 that	G1-NH2	 still	 binds	
to	the	surface	of	V.	harveyi	and	modifies	its	surface	properties,	
potentially	preventing	the	natural	tendency	of	microbes	to	ag-
gregate.	A	 similar	 reduction	 in	 size	 could	be	observed	as	well	
for	 the	 population	 of	 smaller	 size	 when	V.	 harveyi	 was	 incu-




Further	 evidence	 of	 the	 interaction	 between	 Gn-NH2	 den-
drimers	 and	 V.	 harveyi	 was	 obtained	 from	 ζ-potential	 meas-
urements.	As	expected,	the	bacteria	presented	an	overall	neg-
ative	 potential	 (-64.4	 ±	 5.9	mV,	 Figure	 S6),	 representative	 of	
their	 negatively	 charged	 membranes.	 In	 the	 presence	 of	 the	
dendrimers	 however	 this	 negative	 potential	 was	 reduced.	





with	 SYTO-9,	 a	 fluorescent	 green	dye	 permeable	 to	microbial	




labelled	 G3-NH2	 is	 present	 throughout	 the	 cluster.	 The	 high	
density	of	white	fluorescent	clusters	and	the	absence	of	green	
fluorescence	 within	 the	 clusters	 indicates	 colocalization	 of	



















we	 decided	 to	 investigate	 the	 ability	 of	 these	 dendrimers	 to	
modulate	the	expression	of	quorum	sense	controlled	lumines-
cence	in	V.	harveyi.	We	anticipated	that	a	generation	depend-
ent	 effect	 on	 the	 production	 of	 light	 should	 be	 observed,	 in	
agreement	 to	 that	 identified	 during	 the	 aggregation	 experi-
ments	 (Figure	 2-Figure	 1).	When	 V.	 harveyi	 BB170	 was	 incu-
bated	with	these	dendrimers,	a	significant	increase	in	the	pro-
duction	 of	 light	 was	 observed	 that	 was	 proportional	 to	 the	
amount	of	dendrimer	added	(Figure	S9-Figure	S11).	When	the	
same	 concentration	 of	 amines	 (e.g.	 0.5	 mM)	 was	 evaluated	
across	the	different	dendrimers	used,	a	clear	generation	effect	
could	 be	 observed	 (Figure	 3).	 Light	 production	 in	 V.	 harveyi	
was	 increased	 more	 than	 ten	 times	 when	 it	 was	 incubated	
with	 G1-NH2	 at	 this	 concentration,	 and	 over	 two	 orders	 of	
magnitude	when	treated	with	the	highest	generations	of	den-
drimers.	
This	 increase	was	also	apparent	when	we	evaluated	 the	 time	
taken	by	bacteria	 to	recover	 the	 initial	 levels	of	 luminescence	
(∼3	 x	 103,	 Figure	 3B).	 Under	 normal	 conditions,	 V.	 harveyi	
switches	off	 light	production	 following	dilution	 into	 the	 assay	
broth	and	it	takes	almost	8	h	for	V.	harveyi	to	reach	a	popula-
tion	 density	 that	 can	 produce	 similar	 levels	 of	 luminescence	
than	the	levels	observed	at	the	beginning	of	the	experiment.	In	
the	presence	of	these	GATG	dendrimers	however,	this	level	of	
luminescence	could	be	reached	 in	as	 little	as	6	h	 for	 the	den-
drimers	 of	 higher	 generation	 (Figure	 3C).	 This	 generation	 ef-
fect	 in	 recovery	 time	was	also	observed	at	 the	other	 concen-
trations	of	amino	groups	tested	(0.25	and	1	mM,	Figure	S12).	
Such	a	significant	 increase	 in	 luminescence	was	noticeable,	 in	
particular	 considering	 the	 poor	 ability	 of	 G1-NH2	 to	 cluster	
bacteria	 (Figure	2).	This	enhancement	of	 light	production	was	
even	 more	 remarkable	 when	 we	 evaluated	 the	 effect	 these	
GATG	dendrimers	had	on	the	growth	of	V.	harveyi.	Monitoring	
of	 optical	 density	 at	 600	nm	 (OD600)	 during	 the	 luminescence	
experiments	showed	that	all	three	Gn-NH2	were	able	to	delay	
growth	in	V.	harveyi	(Figure	S13-Figure	S14),	suggesting	that	V.	
harveyi	 were	 achieving	 similar	 levels	 of	 light	 production	 at	
even	 lower	 densities	 of	 bacteria.	 This	 effect	 was	 dose-
dependent,	 but	 not	 generation	 dependent,	 with	 higher	 con-
centrations	of	dendrimers	showing	the	highest	effect	in	micro-
bial	 growth.	Remarkably,	even	at	 the	 lowest	 concentration	of	









have	 an	 alternative	mode	 of	 antimicrobial	 activity.	 In	 this	 re-
gard,	 delayed	 growth	 of	 V.	 harveyi	 in	 the	 presence	 of	 these	
GATG	dendrimers	was	observed	at	the	highest	concentrations	
tested	 during	 luminescence	 (Figure	 S14),	 suggesting	 a	 poten-
tial	bacteriostatic	effect.	
Incubation	 of	 V.	 harveyi	 (under	 the	 aggregation	 assay	 condi-
tions)	with	 a	mixture	 of	 SYTO-9	 and	 propidium	 iodide	 (green	
and	red	stains	 for	cells	with	 intact	and	damaged	membranes)	
revealed	 that	 as	 the	 generation	 of	 dendrimers	 increased,	 a	
growing	 number	 of	 bacteria	 were	 stained	 red	 (Figure	 4	 and	
Figure	S7).	 This	 increase	 in	 red	 staining	 is	 indicative	of	higher	
permeability	of	the	membrane	with	larger	generations	of	den-
drimer.	 While	 membrane	 permeability	 for	 G1-NH2	 was	 not	
higher	than	control,	over	50%	of	the	bacteria	were	stained	red	
in	 the	 presence	 of	 G2-NH2	 and	 up	 to	 85%	 in	 the	 case	 of	 G3-





ured	 by	 flow	 cytometry.	V.	 harveyi	 was	 incubated	 in	 the	 absence	 (control)	 and	













generations	 of	 dendrimers	 tested	 (Figure	 S13).	 Accordingly,	
any	 reduction	 of	 the	 amount	 of	 light	 produced	 as	 a	 result	 of	
the	slower	growth	of	V.	harveyi	should	affect	equally	all	gener-
ations.	 At	 the	 same	 time,	 these	 dendrimers	 were	 inducing	 a	
generation	dependent	clustering	and	thereby	were	 likely	acti-
vating	 quorum	 sense	 controlled	 light	 production	 in	 the	 order	
G1<G2<G3	(Figure	2-Figure	3).18	Moreover,	membrane	perme-
ability	 assays	 showed	 that	 G2	 and	 G3	 dendrimers	 led	 to	 in-
creasing	 membrane	 permeability	 under	 the	 conditions	 em-
ployed	to	monitor	aggregation	(Figure	4),	an	effect	that	was	al-
so	observed	when	 this	permeability	assay	was	performed	un-
der	 the	 luminescence	assay	 conditions	 (Figure	S8).	 This	 is	not	
unexpected,	 as	 membrane	 disruption	 has	 been	 observed	 for	
primary	amines	 in	multivalent	 scaffolds,	but	can	be	alleviated	
if	wanted	with	 alternative	 cationic	GATG	dendrimers	 carrying	
secondary/tertiary	amines	or	quaternary	ammonium	salts.26-28	
This	 increased	 permeability	 caused	 by	 the	 higher	 generation	
dendrimers	could	facilitate	the	diffusion	of	quorum	sensing	au-
toinducers	 inside	 the	 periplasm	 and	 thus	 enhance	 light	 pro-
duction	 from	 the	 bacteria.	 Experiments	 to	 elucidate	 the	 rela-
tive	 contributions	 of	 aggregation	 and	 permeability	 on	 light	




ic	 GATG	 dendrimers	 interact	 with	 bacteria,	 interactions	 that	
could	result	in	antimicrobial	applications	for	this	family	of	den-
drimers.	We	 have	 focused	 our	 evaluation	 in	 3	 areas	 –	 adhe-
sion/clustering,	 signalling	 and	 membrane	 disruption	 –	 where	
we	 anticipate	 these	 dendrimers	 will	 have	 a	 higher	 impact.	




sequestrant	 of	 bacteria.	 Also,	 cationic	 GATG	 dendrimers	 in-
duced	 the	 expression	 of	 quorum	 sense	 controlled	 lumines-
cence	 in	a	generation	dependent	 fashion,	while	 inhibiting	 the	
growth	 of	V.	 harveyi	 at	 the	 highest	 concentrations	 of	 amines	
tested.	Moreover,	 these	 cationic	 dendrimers	were	 able	 to	 in-
crease	 the	membrane	permeability	of	 the	bacteria,	again	 in	a	
generation	 dependent	 manner.	 These	 results	 together	 high-
light	the	potential	of	GATG	dendritic	materials	as	a	platform	to	
develop	 new	antimicrobials	 that	 can	 target	microbial	 viability	
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